Biotech: Pressemitteilungen - Kategorie - Seite 19

Biotech

Category / Pharmaceuticals & Biotech / Biotech


Aevi Genomic Medicine Announces Enrollment of First Patient in Phase 1/2 Clinical Trial of AEVI-001 in 22q Deletion Syndrome

PHILADELPHIA, PA: PHILADELPHIA, PA -- (Marketwired) -- 01/31/17 -- (NASDAQ: GNMX) (the Company) announced today that the first patient has been dosed in a Phase 1/2 clinical trial to assess the efficacy of its lead i ...

Trillium Therapeutics Doses First Patient With TTI-621 in Phase 1 Solid Tumor Trial

TORONTO, ONTARIO: TORONTO, ONTARIO -- (Marketwired) -- 01/31/17 -- Trillium Therapeutics Inc. (NASDAQ: TRIL)(TSX: TR), a clinical-stage immuno-oncology company developing innovative therapies for the treatment of canc ...

Lattice Biologics Ltd. Reports Fourth Quarter and Year End 2016 Highlights

SCOTTSDALE, ARIZONA: New core product sales increase 147% fourth quarter over fourth quarter ...

Corcept Therapeutics Announces Preliminary Fourth Quarter and Full-Year 2016 Financial Results and Corporate Update; Provides 2017 Revenue Guidance

MENLO PARK, CA: MENLO PARK, CA -- (Marketwired) -- 01/30/17 -- Corcept Therapeutics Incorporated (NASDAQ: CORT)Corcept Therapeutics Incorporated (NASDAQ: CORT), a pharmaceutical company engaged in the discovery, dev ...

CORRECTION FROM SOURCE: Calyx Provides Corporate Update

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/30/17 -- This document corrects and replaces the press release that was sent today at 8:00 am ET. The embedded URL was changed.Calyx Bio-Ventures In ...

Calyx Provides Corporate Update

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/30/17 -- Calyx Bio-Ventures Inc. (TSX VENTURE: CYX) ("Calyx" or the "Company") is pleased to provide an update on its ongoing b ...

Court Schedules Hearing To Consider Approval Of Settlement Of Derivative Action

NEW YORK, NY: NEW YORK, NY -- (Marketwired) -- 01/27/17 -- iBio, Inc. (NYSE MKT: IBIO) On January 20, 2017, the Supreme Court for the State of New York, County of New York, scheduled a hearing to consider approval ...

Cellestia Biotech AG: Cellestia Biotech raises CHF 8M seed financing

BASEL, SWITZERLAND: BASEL, SWITZERLAND -- (Marketwired) -- 01/26/17 -- Cellestia Biotech AG -Basel, Switzerland - January 26, 2017 - Cellestia Biotech AG, a private biopharmaceutical company with strategic focus on anti ...

ANGLE plc: Positive Interim Evaluation of Ovarian Cancer Clinical Studies

GUILDFORD, UNITED KINGDOM: GUILDFORD, UNITED KINGDOM -- (Marketwired) -- 01/26/17 -- Angle PLC (AIM: AGL) (OTCQX: ANPCY)AIM:AGL OTCQX:ANPCYPatient enrolment European study now over 90% complete and US study 70% complete; Headl ...

Acquisition and Disposition of Securities of Hemostemix Inc.

CALGARY, ALBERTA: CALGARY, ALBERTA -- (Marketwired) -- 01/25/17 -- Wood Capital Ltd. ("Wood Capital") an entity controlled by Blake Wood, acquired a CDN$1,000,000 convertible debenture (the "Debenture& ...

Acquisition and Disposition of Securities of Hemostemix Inc.

CALGARY, ALBERTA: CALGARY, ALBERTA -- (Marketwired) -- 01/25/17 -- Drive Capital Corp. ("Drive Capital") an entity controlled by Jed M. Wood, acquired a CDN$1,000,000 convertible debenture (the "Debent ...

Aldeyra Therapeutics Announces Clinical Development Update for Phase 3 Programs

LEXINGTON, MA: LEXINGTON, MA -- (Marketwired) -- 01/25/17 -- Aldeyra Therapeutics, Inc. (NASDAQ: ALDX)Noninfectious Anterior Uveitis: Enrollment of first-ever vehicle-controlled Phase 3 clinical trial is expected t ...

SHYFT Analytics Appoints Joseph Tyers to Chief Revenue Officer

WALTHAM, MA: Life Sciences Software Executive to Lead Commercial Team ...

Prima BioMed to Present at 2nd Annual Cancer Immunotherapy Conference

SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 01/22/17 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima" or the "Company") announces that the submission titled "TACTI-mel, Two A ...

Prima BioMed Commences Randomised Phase IIb Clinical Trial for IMP321 in Breast Cancer

SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 01/19/17 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) ("Prima" or the "Company") today announced the first patient has been dosed as part of ...

Prima BioMed to Maintain NASDAQ Listing

SYDNEY, AUSTRALIA: SYDNEY, AUSTRALIA -- (Marketwired) -- 01/18/17 -- Prima BioMed Ltd (ASX: PRR) (NASDAQ: PBMD) the "Company" has received notification from the Listing Qualifications Department of the NASDAQ ...

Theratechnologies Inc.: Ibalizumab 24-Week Pivotal Phase III Study Results Accepted as a Late Breaker Will Be Presented at CROI 2017

MONTREAL, QUEBEC: MONTREAL, QUEBEC -- (Marketwired) -- 01/17/17 -- Theratechnologies Inc. (Theratechnologies) (TSX: TH) announces that the abstract submitted by its partner, TaiMed Biologics, Inc., for the 24-week st ...

Beyond the Smoke Stacks: Texas Ropes in $4 Billion Pharma-Bio Investment, an Industrial Info News Alert

SUGAR LAND, TX: SUGAR LAND, TX -- (Marketwired) -- 01/17/17 -- Reported by Annette Kreuger, Industrial Info Resources (Sugar Land, Texas) -- When many people hear the word "Texas," it evokes a number of cl ...

SpeeDx and UgenTec launch FastFinder for ResistancePlus MG Test

SYDNEY, AUSTRALIA and HASSELT, BELGIUM: Artificially intelligent interpretation module automatically incorporates test results into lab information systems ...

Valens GroWorks Licensing Inspection Completed

VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 01/13/17 -- Valens GroWorks Corp. (CSE: VGW)(CSE: VGW.CN)(the "Company") is pleased to announce the completion, by the Regional Inspectorate ...


Seite 19 von 255:  « ..  18 19 20  21  22  23  24  25  26  27  .. » 255





 

Werbung



Facebook

Sponsoren

foodir.org The food directory für Deutschland
Informationen für Feinsnacker finden Sie hier.

Firmenverzeichniss

Firmen die firmenpresse für ihre Pressearbeit erfolgreich nutzen
1 2 3 4 5 6 7 8 9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z